GlaxoSmithKline(MX:GSKN)
MX$960.00+8.24 (+0.87%)
MX:GSKN
GlaxoSmithKline earnings date
MX$960.00
At close:+8.24 (+0.87%)
GlaxoSmithKline (GSKN) Q3 2022 Earnings Report
0 Followers
MX:GSKN Q3 2022 EPS Results
- Actual EPS
- MXN 19.99
- Consensus EPS
- MXN 16.72
- Beat/Miss
- Beat by +MXN 3.27
- One Year Ago EPS
- MXN 18.86
MX:GSKN Q3 2022 Revenue Results
- Actual Revenue
- MXN 171.27B
- Expected Revenue
- MXN 154.61B
- Beat/Miss
- Beat by +MXN 16.66B
- YoY Revenue Growth
- -26.37%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/02/2022
- Time
- Before Open
- Conference Call
- Wednesday, November 2, 2022
MX:GSKN Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
MX:GSKN Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GSKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 13.76- | 12.96 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 24.7727.01 | 27.1 | -0.34% (-0.09) | |
| Jul 28, 2026 | 2026 (Q2) | 23.0624.96 | 22.99 | 8.58% (+1.97) | |
| Apr 29, 2026 | 2026 (Q1) | 21.4823.36 | 22.3 | 4.75% (+1.06) | |
| Feb 04, 2026 | 2025 (Q4) | 11.9412.96 | 10.81 | 19.97% (+2.16) | |
| Oct 29, 2025 | 2025 (Q3) | 23.3827.10 | 24.05 | 12.68% (+3.05) | |
| Jul 30, 2025 | 2025 (Q2) | 21.7822.99 | 20.74 | 10.85% (+2.25) | |
| Apr 30, 2025 | 2025 (Q1) | 19.4422.30 | 20.03 | 11.33% (+2.27) | |
| Feb 05, 2025 | 2024 (Q4) | 9.1010.81 | 13.69 | -21.06% (-2.88) | |
| Oct 30, 2024 | 2024 (Q3) | 21.4324.05 | 22.73 | 5.81% (+1.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


